{"DataElement":{"publicId":"3283752","version":"1","preferredName":"Disease or Disorder Status Reduced Pigmentation Disease or Disorder Status Type","preferredDefinition":"A description of the disease status of pigmentary dilution disorder.","longName":"2512861v1.0:3283408v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2512861","version":"1","preferredName":"Disease or Disorder Status","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time.","longName":"2404658v1.0:2320064v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898979-184A-3A90-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3283408","version":"1","preferredName":"Reduced Pigmentation Disease or Disorder Status Type","preferredDefinition":"Made less in size or amount or degree._Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time._Type; a subdivision of a particular kind of thing.","longName":"3283408v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No prior accelerated phase","valueDescription":"Negation Prior Accelerated Phase of Disease","ValueMeaning":{"publicId":"3283410","version":"1","preferredName":"Negation Prior Accelerated Phase of Disease","longName":"3283410","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Earlier in time or order.: The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Accelerated Phase of Disease","conceptCode":"C36155","definition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8B1BBC-28B8-8F0E-E040-BB89AD4364FD","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8B1BBC-28D1-8F0E-E040-BB89AD4364FD","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"},{"value":"In accelerated phase","valueDescription":"Accelerated Phase of Disease","ValueMeaning":{"publicId":"3283411","version":"1","preferredName":"Accelerated Phase of Disease","longName":"3283411","preferredDefinition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accelerated Phase of Disease","conceptCode":"C36155","definition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8B1BBC-28DD-8F0E-E040-BB89AD4364FD","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8B1BBC-28F6-8F0E-E040-BB89AD4364FD","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"},{"value":"In remission from accelerated phase","valueDescription":"Remission From Accelerated Phase of Disease","ValueMeaning":{"publicId":"3283409","version":"1","preferredName":"Remission From Accelerated Phase of Disease","longName":"3283409","preferredDefinition":"An abatement in intensity or degree (as in the manifestations of a disease).: Used to indicate a specified place or time as a starting point.: The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Remission","conceptCode":"C18246","definition":"An abatement in intensity or degree (as in the manifestations of a disease).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"From","conceptCode":"C25516","definition":"Used to indicate a specified place or time as a starting point; used to indicate a source, cause, agent, or instrument.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Accelerated Phase of Disease","conceptCode":"C36155","definition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8B1BBC-2891-8F0E-E040-BB89AD4364FD","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8B1BBC-28AA-8F0E-E040-BB89AD4364FD","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8B1BBC-290A-8F0E-E040-BB89AD4364FD","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4289184","version":"1","preferredName":"Reduced Pigmentation Disease or Disorder Status Type","preferredDefinition":"Made less in size or amount or degree.:Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A condition or state at a particular time.:Something distinguishable as an identifiable class based on common qualities.","longName":"4289184v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Pigmentation","conceptCode":"C38005","definition":"Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F87033C1-820C-C5F9-E040-BB89AD4336CC","latestVersionIndicator":"Yes","beginDate":"2014-05-02","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-02","modifiedBy":"ONEDATA","dateModified":"2014-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8B1BBC-2877-8F0E-E040-BB89AD4364FD","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"KUMMEROA","dateModified":"2021-01-05","changeDescription":". 2021-1-5 ak Ok to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3279240","version":"1","longName":"2032r1: Chediak-Higashi Syndrome Pre-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"}]}],"AlternateNames":[{"name":"chs_base_dx_status_prior","type":"NMDP_FN","context":"NHLBI"},{"name":"PDDpost_dis_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"PDDpre_dis_stat_prep_dis_stat","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the disease status o","type":"Preferred Question Text","description":"What was the disease status of the reduced pigmentation disorder?","url":null,"context":"NHLBI"},{"name":"What was the disease status?","type":"Alternate Question Text","description":"What was the disease status?","url":null,"context":"NHLBI"},{"name":"What was the disease status?","type":"Application Standard Question Text","description":"What was the disease status?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8B1BBC-2A76-8F0E-E040-BB89AD4364FD","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"KUMMEROA","dateModified":"2021-01-05","changeDescription":". 2021-1-5 ak OK to release per WZ. System generated def displayed as alt def. AK 11/3/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}